Literature DB >> 25963032

[Hypertrophic and restrictive cardiomyopathy. Differentiation by imaging].

S Fritschi1, M Prothmann, J Schulz-Menger.   

Abstract

The differentiation between hypertrophic and restrictive cardiomyopathies is often challenging in the routine clinical setting. Advances in the field of multimodal imaging have improved the diagnostics of these diseases and understanding of the underlying pathophysiology. Each imaging method, such as echocardiography, cardiac magnetic resonance imaging (CMR), cardiac computed tomography (CT) and coronary angiography including cardiac catheterization for pressure measurements, is of significant value in clinical diagnostics and also regarding therapeutic approaches and prognostic implications. This review gives an overview of developments of the past few years, describes recent insights and puts these findings into a scientific context. Particularly CMR has added valuable information to current knowledge by its unique potential of contrast-enhanced tissue characterization. Another promising CMR tool, parametric mapping has appeared on the horizon and may further deepen our understanding of cardiac pathophysiology as well as offer new therapeutic options to patients.

Entities:  

Mesh:

Year:  2015        PMID: 25963032     DOI: 10.1007/s00059-015-4231-5

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  59 in total

1.  Single-centre survey of the application of cardiovascular magnetic resonance in clinical routine.

Authors:  Florian von Knobelsdorff-Brenkenhoff; Angelika Bublak; Sana El-Mahmoud; Ralf Wassmuth; Christian Opitz; Jeanette Schulz-Menger
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2012-06-26       Impact factor: 6.875

Review 2.  Contrast echocardiography: evidence-based recommendations by European Association of Echocardiography.

Authors:  Roxy Senior; Harald Becher; Mark Monaghan; Luciano Agati; Jose Zamorano; Jean Louis Vanoverschelde; Petros Nihoyannopoulos
Journal:  Eur J Echocardiogr       Date:  2009-03

3.  Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.

Authors:  Jose Angel Urbano-Moral; Ethan J Rowin; Martin S Maron; Andrew Crean; Natesa G Pandian
Journal:  Circ Cardiovasc Imaging       Date:  2013-11-25       Impact factor: 7.792

4.  Two-dimensional strain analysis of the global and regional myocardial function for the differentiation of pathologic and physiologic left ventricular hypertrophy: a study in athletes and in patients with hypertrophic cardiomyopathy.

Authors:  T Butz; F van Buuren; K P Mellwig; C Langer; G Plehn; A Meissner; H J Trappe; D Horstkotte; L Faber
Journal:  Int J Cardiovasc Imaging       Date:  2010-07-10       Impact factor: 2.357

5.  Relative apical sparing of longitudinal strain using two-dimensional speckle-tracking echocardiography is both sensitive and specific for the diagnosis of cardiac amyloidosis.

Authors:  Dermot Phelan; Patrick Collier; Paaladinesh Thavendiranathan; Zoran B Popović; Mazen Hanna; Juan Carlos Plana; Thomas H Marwick; James D Thomas
Journal:  Heart       Date:  2012-08-03       Impact factor: 5.994

6.  Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention.

Authors:  Barry J Maron; Jeffrey A Towbin; Gaetano Thiene; Charles Antzelevitch; Domenico Corrado; Donna Arnett; Arthur J Moss; Christine E Seidman; James B Young
Journal:  Circulation       Date:  2006-03-27       Impact factor: 29.690

7.  Cardiovascular magnetic resonance in cardiac amyloidosis.

Authors:  Alicia Maria Maceira; Jayshree Joshi; Sanjay Kumar Prasad; James Charles Moon; Enrica Perugini; Idris Harding; Mary Noelle Sheppard; Philip Alexander Poole-Wilson; Philip Nigel Hawkins; Dudley John Pennell
Journal:  Circulation       Date:  2005-01-03       Impact factor: 29.690

8.  Myocardial fibrosis severity on cardiac magnetic resonance imaging predicts sustained arrhythmic events in hypertrophic cardiomyopathy.

Authors:  Christian Prinz; Maria Schwarz; Ivan Ilic; Kai Thorsten Laser; Roman Lehmann; Eva-Maria Prinz; Thomas Bitter; Jürgen Vogt; Frank van Buuren; Nikola Bogunovic; Dieter Horstkotte; Lothar Faber
Journal:  Can J Cardiol       Date:  2012-06-30       Impact factor: 5.223

9.  The prevalence and prognostic significance of right ventricular systolic dysfunction in nonischemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Francisco Alpendurada; Kaushik Guha; Nizar A Ismail; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Kishen Morarji; Emmanouil Liodakis; Michael Roughton; Ricardo Wage; Tapesh C Pakrashi; Rakesh Sharma; John-Paul Carpenter; Stuart A Cook; Martin R Cowie; Ravi G Assomull; Dudley J Pennell; Sanjay K Prasad
Journal:  Circulation       Date:  2013-08-21       Impact factor: 29.690

10.  Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy.

Authors:  Ankur Gulati; Tevfik F Ismail; Andrew Jabbour; Nizar A Ismail; Kishen Morarji; Aamir Ali; Sadaf Raza; Jahanzaib Khwaja; Tristan D H Brown; Emmanouil Liodakis; Arun J Baksi; Rameen Shakur; Kaushik Guha; Michael Roughton; Ricardo Wage; Stuart A Cook; Francisco Alpendurada; Ravi G Assomull; Raad H Mohiaddin; Martin R Cowie; Dudley J Pennell; Sanjay K Prasad
Journal:  Eur J Heart Fail       Date:  2013-03-08       Impact factor: 15.534

View more
  1 in total

1.  Restrictive cardiomyopathy : Delayed occurrence after radiotherapy of breast cancer.

Authors:  Barbara Bellmann; Brunilda Alushi; Boris Bigalke; Ulf Landmesser; Andreas J Morguet
Journal:  Wien Klin Wochenschr       Date:  2016-11-11       Impact factor: 1.704

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.